IL17A and myeloid sarcoma: Immunohistochemical analyses for IL-17 [Fig. 9A; densitometric analysis Fig. 9F] and IFN-γ [Fig. 9G; densitometric analysis Fig. 9L] expression revealed marked positive staining for these markers in EAE mice, while negative staining was noticed in EAE mice treated with hPDLSCs-CM or hPDLSCs-EMVs derived from MS patients [Fig. 9B,C and H,I, respectively] and donors [Fig. 9D,E and J,K, respectively].